Magalang, Jennifer V.
HRN: 08-69-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/12/2024
10/18/2024
IVT
600mg
Q8
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes